Anthon Jahreskog

(Mr. Anthon Jahreskog)

Currently holds positions in Infant Bacterial Therapeutics AB and Biogaia AB

Positions
Position Company Period
Director Infant Bacterial Therapeutics AB May 15, 2018 -
Independent Director Biogaia AB May 7, 2015 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-03-04 2024-03-04
B Purchase
422
80.00
33,760 SEK 		422 80.00 33,760 SEK
2024-03-04 2024-03-04
B Purchase
38
79.80
3,032 SEK 		38 79.80 3,032 SEK
2024-02-08 2024-02-08
B Purchase
161
94.00
15,134 SEK 		161 94.00 15,134 SEK
2024-02-08 2024-02-08
B Purchase
839
94.20
79,034 SEK 		839 94.20 79,034 SEK
2023-12-13 2023-12-13
B Purchase
700
86.20
60,340 SEK 		700 86.20 60,340 SEK
2023-12-13 2023-12-13
B Purchase
350
86.00
30,100 SEK 		350 86.00 30,100 SEK
2023-08-02 2023-08-02
SE Biogaia AB (BIOG-B)
B Purchase
169
107.00
18,083 SEK 		169 107.00 18,083 SEK
2023-08-02 2023-08-02
SE Biogaia AB (BIOG-B)
B Purchase
481
107.10
51,515 SEK 		481 107.10 51,515 SEK
2023-07-03 2023-06-29
B Purchase
640
45.00
28,800 SEK 		640 45.00 28,800 SEK
2023-06-28 2023-06-26
B Purchase
200
45.00
9,000 SEK 		200 45.00 9,000 SEK
2023-05-23 2023-05-23
B Purchase
149
42.08
6,270 SEK 		149 42.08 6,270 SEK
2023-05-23 2023-05-23
B Purchase
851
43.00
36,593 SEK 		851 43.00 36,593 SEK
2023-05-23 2023-05-23
B Purchase
149
42.80
6,377 SEK 		149 42.80 6,377 SEK
2023-03-13 2023-03-13
SE Biogaia AB (BIOG-B)
B Purchase
540
94.15
50,841 SEK 		540 94.15 50,841 SEK
2023-03-10 2023-03-10
SE Biogaia AB (BIOG-B)
B Purchase
1,700
93.95
159,715 SEK 		1,700 93.95 159,715 SEK
2022-02-10 2022-02-10
B Purchase
350
59.40
20,790 SEK 		350 59.40 20,790 SEK
2022-02-10 2022-02-10
B Purchase
650
59.50
38,675 SEK 		650 59.50 38,675 SEK
2021-06-29 2021-06-29
B Purchase
1,200
94.50
113,400 SEK 		1,200 94.50 113,400 SEK